ArticleCancer immunology, immunotherapy : CII2022

PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients.

Yanni Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.